Synergistic and individual effects of umbelliferone with 5-fluorouracil on tumor markers and antioxidant status of rat treated with 1,2-dimethylhydrazine

Biomedicine and Aging Pathology

Volumn 3, Issue 4, 2013, Pages 219-227

  Muthu, R ^a   Vaiyapuri, M ^a  

^a PERIYAR UNIVERSITY   (India)

Author keywords

5 fluorouracil; Colon cancer; Complementary medicines; Lipid peroxidation; Umbelliferone

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CATALASE; FLUOROURACIL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; LIPID HYDROPEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR MARKER; UMBELLIFERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; METASTASIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 84889081797     PISSN: 22105220     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomag.2013.08.007     Document Type: Article

References (53)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA: Cancer J Clin 61 2011 69 90
2. National Institutes of Cancer Cancer advances in focus: colorectal cancer 2010 National Institutes of Cancer Bethesda, MD
3. Y.H. Zhang, Y. Li, and C. Chen Carcinoembryonic antigen level is related to tumor invasion into the serosa of the stomach: study on 166 cases and suggestion for new therapy Hepatogastroenterology 56 2009 285 289
4. T.D. Veenstra, D.A. Prieto, and T.P. Conrads Proteomic patterns for early cancer detection Drug Dicov Today 9 2004 889 897
5. T.P. Conrads, B.L. Hood, and H.J. Issaq Proteomic patterns as a diagnostic tool for earlystage cancer: a review of its progress to a clinically relevant tool Mol Design 8 2004 77 85
6. X.Q. Yang, L. Yan, and C. Chen Application of C12 multitumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement Hepatogastroenterology 56 2009 1388 1394
7. A. Figueredo, R.B. Rumble, and J. Maroun Follow-up of patients with curatively resected colorectal cancer: a practice guideline BMC Cancer 3 2003 26 39
8. G.J. Bosl, D.F. Bajorin, J. Sheinfeld, R.J. Motzer, and R.S. Chaganti Cancer of the testis V.T. DeVita, S. Hellman, S.A. Rosenberg, Cancer, principles and practice of oncology 6th ed. 2001 Lippincott, Williams & Wilkins Philadelphia 1491 1518
9. M. Carpelan-Holmstrom, J. Louhimo, and U.H. Stenman C EA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer Tumour Biol 25 5-6 2004 228 234
10. T. Devasena, V.P. Menon, and K.N. Rajasekharan Prevention of 1,2-dimethylhydrazine-induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione during colon carcinogenesis Pharmacol Rep 58 2006 229 235
11. H.J. Harzallah, A. Neffati, I. Skandrani, E. Maaloul, L. Chekir-Ghedira, and T. Mahjoub Antioxidant and antigenotoxic activities of Globularia alypum leaves extracts Journal of Medicinal Plant Research 419 2010 2048 2053
12. S. Vertuani, A. Angusti, and S. Manfredini The antioxidants and pro-antioxidants network: an overview Curr Pharm Des 10 2004 1677 1694
13. W. Sun, and D.G. Haller Adjuvant therapy for colon cancer Curr Oncol Rep 7 2005 181 185
14. C.G. Leichman Adjuvant therapy for colon cancer 2005: new options in the twenty-first century Surg Oncol Clin N Am 15 2006 159 173
15. A.D. Fishman, and S. Wadler Advances in the treatment of metastatic colorectal cancer Clin Colorectal Cancer 1 2001 20 35
16. R. O'kennedy, and R.D. Thornes Coumarins - biology, applications and mode of action 1997 Wiley Chichester 312 314
17. S.A. Wohaieb, and D.V. Godin Diabetes 36 1987 1014 1018
18. B. Ramesh, and K.V. Pugalendi Life Sci 79 2006 306 310
19. B. Ramesh, and K.V. Pugalendi Antihyperglycaemic effect of umbelliferone in STZ-diabetic rats J Med Food 9 2006 562 566
20. B. Ramesh, and K.V. Pugalendi Antihyperlipidemic and antidiabetic effects of umbelliferone in streptozotocin diabetic rats Yale J Biol Med 78 2005 189 196
21. M.G. Repetto, and S.F. Llesuy Braz J Med Biol Res 35 2002 523 534
22. V. Manju, and N. Nalini Effect of ginger on lipid peroxidation and antioxidant status in 1,2-dimethylhydrazine induced experimental colon carcinogenesis J Biochem Tech 2 2010 161 167
23. B. Ramesh, and K.V. Pugalendi Impact of umbelliferone (7-hydroxycoumarin) on hepatic marker enzymes in streptozotocin diabetic rats Ind j pharma 38 2006 209 210
24. Hee Yi, Hee-Jung Cho, Soo-Min Cho, and Dong-Goo Lee Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel BMC Cancer 10 2010 1 8
25. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbiuric acid reaction Anal Biochem 95 1979 351 358
26. K. Yagi Lipid peroxides and human disease Chem Phys Lip 45 1978 337 351
27. G.L. Ellman Tissue sulfhydryl groups Arch Biochem Biophys 82 1959 70 77
28. J.T. Rotruck, A.L. Pope, H.E. Ganther, A.B. Swanson, D.G. Hateman, and W.G. Hoekstra Selenium: biochemical role as a component of Glutathione peroxidase Sci 179 1973 588 590
29. P.S. Kakkar, B. Das, and P.N. Viswanathan A modified spectrophotometric assay of super oxide dismutase Ind J Biochem Biophy 21 1984 130 132
30. K.A. Sinha Colorimetric assay of catalase Annul Biochem 47 1972 387 389
31. C.J. Abeyounis, and F. Milgram Studies on carcino embryonic antigen Int Arch Allergy Appl Immunol 43 1972 30 39
32. B.D. Duncan Multiple range test for correlated and lesenoscedastic means Biometrics 13 1957 359 364
33. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, and A. Ghafoor Cancer statistics, 2005 CA Cancer J Clin 55 2005 10 30
34. S. Winawer, R. Fletcher, D. Rex, J. Bond, R. Burt, and J. Ferrucci Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence Gastroenterology 124 2003 544 560
35. T. Morikawa, J. Kato, and Y. Yamaji A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population Gastroenterology 129 2005 422 428
36. H. Narimatsu, H. Sawaki, A. Kuno, H. Kaji, H. Ito, and Y. Ikehara A strategy for discovery of cancer glycol-biomarkers in serum using newly developed technologies for glycoproteomics FEBS J 277 2010 95 105
37. D. Shirit, B. Zingerman, A.B. Shirit, D. Shlomi, and M.R. Kramer Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature Oncologist 10 2005 501 507
38. I.J. Park, H.C. Kim, C.S. Yu, J.H. Yoo, and J.C. Kim Cutoff values of preoperatives - CEA levels for predicting survivals after curative resection of colorectal cancer J Korean Med Sci 20 2005 624 627
39. W.C. Lin, Y.T. Tseng, Y.L. Chang, and Y.C. Lee Pulmonary tumour with high carcinoembryonic antigen titre caused by chronic propolis aspiration Eur Respir J 30 2007 1227 1230
40. J. Haier, and G.L. Nicolson The role of tumor cell adhesion as an important factor in formation of distant colorectal metastasis Dis Colon Rectum 44 2001 876 884
41. P. Flamen, O.S. Hoekstra, F. Homans, E. Van Cutsem, A. Maes, and S. Stroobants Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET) Eur J Cancer 37 2001 862 869
42. S. Morita, T. Nomura, and Y. Fukushima Does serum CA19-9 play a practical role in the management of patients with colorectal cancer? Dis Colon Rectum 47 2004 227 232
43. N.M. Forones, and M. Tanaka CEA and CA19-9 as prognostic indexes in colorectal cancer Hepatogastroenterology 46 1999 905 908
44. I.J. Papk, G.S. Choi, and S.H. Jun Prognostic value of serum tumor antigen ca19-9 after curative resection of colorectal cancer Anticancer Res 29 2009 4303 4308
45. L. Fernandez fernandez, E. Tejero, and A. Tieso Significance of CA72-4 in colorectal carcinoma. Comparison with CEA and CA19-9 Eur J Surg Oncol 21 1995 388 390
46. G. Ekambaram, P. Rajendran, V. Magesh, and D. Sakthisekaran Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine- induced gastric carcinogenesis inrats Nutr Res 28 2008 106 112
47. K. Selvendiran, J.P. Singh, K.B. Krishnan, and D. Sakthisekaran Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice Fitoterapia 74 2003 109 115
48. P. Anandakumar, S. Kamaraj, S. Jagan, G. Ramakrishnan, R. Vinodhkumar, and T. Devaki Capsaicin modulates pulmonary antioxidant defense system during benzo(a)pyrene-induced lung cancer in swiss albino mice Phytother Res 22 2008 529 533
49. G. Ramakrishnan, H.R. Raghavendran, R. Vinodhkumar, and T. Devaki Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats Chem Biol Interact 161 2006 104 114
50. G. Waris, and H. Ahsan Reactive oxygen species: role in the development of cancer and various chronic conditions J Carcinogen 2006 14
51. E.M. Schmelz, M.C. Sullards, D.L. Dillehay, and A.H. Merrill Jr. Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1,2-dimethylhydrazine-treated CF1 mice J Nutr 130 2000 522 527
52. K. Nakagami, T. Uchida, S. Ohwada, Y. Koibuchi, and Y. Morishita Increased choline kinase activity in 1,2-dimethylhydrazine-induced rat colon cancer Jpn J Cancer Res 90 1999 1212 1217
53. P.K. Dudeja, and T.A. Brasitus 1,2-dimethylhydrazine-induced alterations in lipid peroxidation in preneoplastic and neoplastic colonic tissues Biochem Biophys Acta 1046 1990 267 270